B38
/ Luhe Hospital, Chinese Academy of Sciences
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 05, 2026
Hydrogen-Deuterium Exchange Mass Spectrometry Reveals an Antibody-Induced Allosteric Pathway Driving SARS-CoV-2 Spike Trimer Disassembly.
(PubMed, J Am Chem Soc)
- "Here, we integrate pulsed hydrogen-deuterium exchange mass spectrometry (HDX-MS), biolayer interferometry (BLI), and negative-stain electron microscopy (nsEM) to dissect the dynamic regulation of two engineered spike (S) protein constructs, the prefusion-stabilized S-6P and the wild-type-like S-R, by two antibody classes: the noncompetitive RBD class V antibody R1-32 and the competitive class I antibody B38...Together, these findings establish a structure-dynamics framework for rational antibody design, emphasizing the targeting of conserved, conformation-sensitive epitopes to outpace viral immune evasion. Moreover, this work highlights pulsed HDX-MS as a powerful approach for resolving antibody-mediated dynamic regulation of the SARS-CoV-2 spike protein, facilitating the development of next-generation broad-spectrum therapeutics against emerging variants."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
March 03, 2022
An engineered bispecific human monoclonal antibody against SARS-CoV-2.
(PubMed, Nat Immunol)
- "A noncompeting pair of human neutralizing antibodies (B38 and H4) blocking SARS-CoV-2 binding to its receptor, ACE2, have been described previously...Furthermore, prophylactic and therapeutic application of bsAb15 reduced the viral titer in infected nonhuman primates and human ACE2 transgenic mice. Therefore, this bsAb is a feasible and effective strategy to treat and prevent severe COVID-19."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1